These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35059568)

  • 21. Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.
    Robertson N; Rappas M; Doré AS; Brown J; Bottegoni G; Koglin M; Cansfield J; Jazayeri A; Cooke RM; Marshall FH
    Nature; 2018 Jan; 553(7686):111-114. PubMed ID: 29300009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1.
    Pandey S; Li XX; Srivastava A; Baidya M; Kumari P; Dwivedi H; Chaturvedi M; Ghosh E; Woodruff TM; Shukla AK
    J Biol Chem; 2019 Jun; 294(24):9416-9429. PubMed ID: 31036565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.
    Zheng QY; Liang SJ; Xu F; Li GQ; Luo N; Wu S; Li Y; Tang M; Zhong Y; Chen J; Yang D; Sun DD; Zhang KQ; Xu GL
    Front Immunol; 2019; 10():1866. PubMed ID: 31447855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
    Laumonnier Y; Karsten CM; Köhl G; Köhl J
    Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.
    Russkamp NF; Ruemmler R; Roewe J; Moore BB; Ward PA; Bosmann M
    FASEB J; 2015 Sep; 29(9):3762-72. PubMed ID: 25999468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients.
    Emtenani S; Holtsche MM; Stahlkopf R; Seiler DL; Burn T; Liu H; Parker M; Yilmaz K; Dikmen HO; Lang MH; Sadik CD; Karsten CM; van Beek N; Ludwig RJ; Köhl J; Schmidt E
    Front Immunol; 2022; 13():942493. PubMed ID: 36466856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of a C5a receptor antagonist in the rat after different sites of enteral administration.
    Morgan M; Bulmer AC; Woodruff TM; Proctor LM; Williams HM; Stocks SZ; Pollitt S; Taylor SM; Shiels IA
    Eur J Pharm Sci; 2008 Apr; 33(4-5):390-8. PubMed ID: 18337070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective effects of argatroban and C5a receptor antagonist (PMX53) following intracerebral haemorrhage.
    Li G; Fan RM; Chen JL; Wang CM; Zeng YC; Han C; Jiao S; Xia XP; Chen W; Yao ST
    Clin Exp Immunol; 2014 Feb; 175(2):285-95. PubMed ID: 24117111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility.
    Tan SM; Ziemann M; Thallas-Bonke V; Snelson M; Kumar V; Laskowski A; Nguyen TV; Huynh K; Clarke MV; Libianto R; Baker ST; Skene A; Power DA; MacIsaac RJ; Henstridge DC; Wetsel RA; El-Osta A; Meikle PJ; Wilson SG; Forbes JM; Cooper ME; Ekinci EI; Woodruff TM; Coughlan MT
    Diabetes; 2020 Jan; 69(1):83-98. PubMed ID: 31624141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
    Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
    MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Potential Link between the C5a Receptor 1 and the β1-Adrenoreceptor in the Mouse Heart.
    Khor KH; Moore TA; Shiels IA; Greer RM; Arumugam TV; Mills PC
    PLoS One; 2016; 11(1):e0146022. PubMed ID: 26727203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1
    Wang HA; Lee JD; Lee KM; Woodruff TM; Noakes PG
    Skelet Muscle; 2017 Jun; 7(1):10. PubMed ID: 28571586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis.
    Chen Y; Li X; Lin X; Liang H; Liu X; Zhang X; Zhang Q; Zhou F; Yu C; Lei L; Xiu J
    Thromb J; 2022 Apr; 20(1):24. PubMed ID: 35488279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study.
    Bekker P; Dairaghi D; Seitz L; Leleti M; Wang Y; Ertl L; Baumgart T; Shugarts S; Lohr L; Dang T; Miao S; Zeng Y; Fan P; Zhang P; Johnson D; Powers J; Jaen J; Charo I; Schall TJ
    PLoS One; 2016; 11(10):e0164646. PubMed ID: 27768695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Role for the Receptor of the Complement Cleavage Fragment C5a, C5aR1, in CCR5-Mediated Entry of HIV into Macrophages.
    Moreno-Fernandez ME; Aliberti J; Groeneweg S; Köhl J; Chougnet CA
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):399-408. PubMed ID: 26537334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
    Li XX; Clark RJ; Woodruff TM
    Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The C5a anaphylatoxin receptor (C5aR1) protects against Listeria monocytogenes infection by inhibiting type 1 IFN expression.
    Calame DG; Mueller-Ortiz SL; Morales JE; Wetsel RA
    J Immunol; 2014 Nov; 193(10):5099-107. PubMed ID: 25297874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C5a receptor1 inhibition alleviates influenza virus-induced acute lung injury.
    Song N; Li P; Jiang Y; Sun H; Cui J; Zhao G; Li D; Guo Y; Chen Y; Gao J; Sun S; Zhou Y
    Int Immunopharmacol; 2018 Jun; 59():12-20. PubMed ID: 29621732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergen-Induced C5a/C5aR1 Axis Activation in Pulmonary CD11b
    Antoniou K; Ender F; Vollbrandt T; Laumonnier Y; Rathmann F; Pasare C; Singh H; Köhl J
    Cells; 2020 Jan; 9(2):. PubMed ID: 31991941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of Human C5a with the Major Peptide Fragments of C5aR1: Direct Evidence in Support of "Two-Site" Binding Paradigm.
    Das A; Behera LM; Rana S
    ACS Omega; 2021 Sep; 6(35):22876-22887. PubMed ID: 34514259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.